Chemical pleurodesis is a therapeutic procedure applied to create the symphysis between
the parietal and visceral pleura by intrapleural administration of various chemical agents (eg …

Background Malignant pleural effusion (MPE) is a common problem for people with cancer
and usually associated with considerable breathlessness. A number of treatment options are …

The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Conservative management can be considered for the treatment of minimally symptomatic
(ie, no significant pain or breathlessness and no physiological compromise) or …

Importance Malignant pleural effusion (MPE) is challenging to manage. Talc pleurodesis is a
common and effective treatment. There are no reliable data, however, regarding the optimal …

Abstract The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Interpreting pleural fluid results correctly requires an awareness of the possible aetiologies
of a pleural effusion and an understanding of the reliability of the outcome of each …

Background Pleurodesis is done as an in-patient procedure to control symptomatic recurrent
malignant pleural effusion (MPE) and has a success rate of 75–80%. Thoracic …

Abstract Roughly 150,000 malignant pleural effusions (MPE) are diagnosed in the United
States each year. The majority of cases are caused by lung and breast cancer, and since …

Exudative pleural effusions, such as malignant and tuberculous pleural effusions, are
associated with notable morbidity and mortality. Unfortunately, a significant number of these …